The double-edged sword: impact of antibiotic use on immunotherapy efficacy in advanced hepatocellular carcinoma
ATB use in the context of immunotherapy for advanced HCC is associated with reduced PFS and OS. Caution is warranted in the administration of ATBs to patients undergoing immunotherapy.
Authors
- Meng Guang-yi
- Guangzhao Wang (ORCID: https://orcid.org/0000-0002-7469-0767)
- Chang Yin Liang (ORCID: https://orcid.org/0000-0003-2317-1323)
- Ziwei Feng
- Shaohuan Lu
- Yang Li (ORCID: https://orcid.org/0009-0005-0604-8501)
Institutions
- Yulin University (CN)
- Yulin Orthopedics Hospital of Chinese and Western Medicine (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1186/s12876-025-03819-w
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Science and Technology Major Project of Guangxi